Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers
Completed · Not applicable
Conditions studied: Breast Cancer, Ovarian Cancer, Pancreatic Cancer, Metastatic Prostate Cancer
In brief
This study is evaluating the effect of two pre-test education methods on participants interested in genetic testing for hereditary cancer risk.
Key facts
- Study ID
- NCT04330716
- Run by
- Dana-Farber Cancer Institute
- People needed
- 269
- Starts
- 2020-12-01
- Expected to finish
- 2023-12-31
- Last updated by the study team
- 2024-01-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Potentially eligible participants will be identified via medical record screening and/or in accordance with their clinical visit. A HIPAA waiver of authorization will be obtained by the enrolling Institution as needed to have access to the subject's medical record information for screening of eligibility.
- A member of the study team will approach the potentially eligible participant in clinic and discuss the trial. Potentially eligible participants may choose to discuss participation further with their physician at their appointment
- Age ≥ 18 years
- Breast, ovarian, pancreatic, or metastatic prostate cancer
- No prior cancer genetic testing
- Ability to understand and the willingness to sign an informed consent document
You may not qualify if…
- Pregnant
- Prisoners
- Inability to understand English as a spoken language in a healthcare context
- Known hematologic malignancy (e.g. CLL)
Where it is running
- Dana-Farber Cancer Institute — Boston, Massachusetts, United States
- Dana-Farber Cancer Institute at St. Elizabeth's Medical Center — Brighton, Massachusetts, United States
- Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center — Milford, Massachusetts, United States
- Dana-Farber/Brigham and Women's Cancer Center in clinical affiliation with South Shore Hospital — Weymouth, Massachusetts, United States
- Dana-Farber/New Hampshire Oncology-Hematology — Londonderry, New Hampshire, United States
- Lifespan Cancer Institute at Rhode Island Hospital — Providence, Rhode Island, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.